Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Indica Labs Nabs CE Mark for AI-Based Prostate Cancer Detection, Gleason Grading Tool
The prostate cancer screening tool is scanner agnostic and was trained using more than 870,000 training patches obtained from the annotation of digital scans.
New Horizon Health, Prenetics to Launch Colorectal Cancer Test in Hong Kong, Macau, Taiwan
The companies first agreed to jointly commercialize the stool-based DNA test, which was developed by New Horizon, in late 2019.
Immunovia Receives Pennsylvania, Maryland Clinical Lab Permits
The company can now provide its ImmRay PanCan-d test to detect stage I and stage II pancreatic cancer in at-risk patients to clinicians in 48 states.
The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.